Epigenesis for epidemiologists: does evo-devo have implications for population health research and practice?
about
Lifecourse health development: past, present and futureOur future: a Lancet commission on adolescent health and wellbeing.Arsenic, antibiotics and interventions.Influence of DNMT genotype on global and site specific DNA methylation patterns in neonates and pregnant women.Prenatal exposure to maternal smoking and offspring DNA methylation across the lifecourse: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC).From stem cells to the law courts: DNA methylation, the forensic epigenome and the possibility of a biosocial archiveTwo-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease.Understanding variation in disease risk: the elusive concept of frailty.Who and what is a "population"? Historical debates, current controversies, and implications for understanding "population health" and rectifying health inequities.Adult height, nutrition, and population health.Childhood Disadvantage and Health Problems in Middle and Later Life: Early Imprints on Physical Health?Approaches for drawing causal inferences from epidemiological birth cohorts: a review.Is epidemiology ready for epigenetics?Entangled lives: Implications of the developmental origins of health and disease hypothesis for bioarchaeology and the life course.Ageing across the Tasman Sea: the demographics and health of older adults in Australia and New Zealand.Cardiovascular mortality in relation to birth weight of children and grandchildren in 500,000 Norwegian families.History, biology, and health inequities: emergent embodied phenotypes and the illustrative case of the breast cancer estrogen receptor
P2860
Q29109901-8E73D052-3B7D-4CCC-AE1B-25F8D6C68F5CQ30250331-63888783-35BD-4971-B195-03FAC1827609Q34649361-37A544C2-95D7-427E-B40C-C6E67C5C2EDCQ35009492-88E466C5-EE38-48B5-B96E-0FA62350804FQ35234088-2EA50539-C903-4AB9-ACEF-D5A3A583E0A1Q35794537-D152DB63-E7B2-434C-A2CD-098195617407Q35832781-5AF228EB-35E7-49DD-9412-EAE1DCFC11AEQ36107633-0C6CA0A2-305C-4421-B3C4-FB256B81706AQ36490211-A6462F83-61C6-466D-99C3-F3B4F9724FBAQ36966803-9A01F690-CA56-4412-AEB0-31FD221CCD88Q37108971-F969BE48-35A2-4E46-A08B-A7C40022B185Q37499341-C73A31F0-5E4E-4CBA-8E2D-D221F5022B33Q38433841-76473E3B-E930-4418-8EF6-366D15C2DE8BQ38696588-4F708895-37C8-4847-8F84-5591C1517252Q39206474-A725816D-2731-4B9D-82FF-6E53C4C4E1F5Q39552859-13E349EF-5BC1-455B-B024-15485A981D71Q57148481-FCF28096-3A7C-46A3-B6D1-6075F0D40BEB
P2860
Epigenesis for epidemiologists: does evo-devo have implications for population health research and practice?
description
article
@en
im Februar 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2012
@uk
name
Epigenesis for epidemiologists ...... health research and practice?
@en
Epigenesis for epidemiologists ...... health research and practice?
@nl
type
label
Epigenesis for epidemiologists ...... health research and practice?
@en
Epigenesis for epidemiologists ...... health research and practice?
@nl
prefLabel
Epigenesis for epidemiologists ...... health research and practice?
@en
Epigenesis for epidemiologists ...... health research and practice?
@nl
P2860
P356
P1476
Epigenesis for epidemiologists ...... health research and practice?
@en
P2860
P304
P356
10.1093/IJE/DYS016
P577
2012-02-01T00:00:00Z